GlassScriptPhysician profile
Sukhjeet S Batth
NPI 1821320011
$7,608.24
in general payments reported to CMS, 2019-2025
51 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what 86% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $3,209 · 2021: $288 · 2022: $962 · 2023: $574 · 2024: $896 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $2,902.30 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $670.03 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $540.04 | 2019-2025 | Tagrisso, Lynparza, Enhertu |
| Novartis Pharmaceuticals Corporation | $387.16 | 2021-2025 | |
| Daiichi Sankyo INC. | $316.60 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Ipsen Biopharmaceuticals, INC | $185.74 | 2019-2025 | Onivyde, Tazverik |
| Sobi, INC | $171.32 | 2022-2025 | |
| Exelixis INC. | $152.16 | 2021-2025 | Cabometyx |
| Merck Sharp & Dohme LLC | $141.28 | 2021-2025 | Keytruda, Welireg |
| Regeneron Healthcare Solutions, INC. | $136.39 | 2019-2024 | Libtayo |
| Varian Medical Systems, INC. | $134.41 | 2019-2020 | |
| Pharmaessentia USA Corporation | $113.95 | 2023-2025 | Besremi |
| Incyte Corporation | $109.22 | 2021-2025 | Monjuvi, Jakafi, Niktimvo |
| Takeda Pharmaceuticals U.S.A., INC. | $105.06 | 2019-2024 | Fruzaqla |
| Astellas Pharma US INC | $103.60 | 2019-2024 | Padcev |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $90.77 | 2020-2023 | Spaceoar Vue System - 10ml, Rezum Generator |
| Amgen INC. | $83.13 | 2021-2022 | |
| Telix Pharmaceuticals | $81.74 | 2023-2025 | Illuccix |
| Lilly USA, LLC | $75.54 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $73.59 | 2019-2023 | Darzalex, Imbruvica |
| Genzyme Corporation | $71.05 | 2023-2025 | |
| Glaxosmithkline, LLC. | $67.55 | 2022-2025 | Ojjaara |
| Emd Serono, INC. | $65.35 | 2022-2024 | |
| Pharmacosmos Therapeutics INC. | $56.66 | 2023-2025 | Monoferric |
| Novocure INC. | $51.36 | 2019-2025 | Optune Lua (Novottf-200t), Optune |
| Octapharma USA, INC. | $45.45 | 2025 | Octagam Immune Globulin (Human) |
| Seagen INC. | $45.23 | 2020-2023 | Padcev |
| Beigene USA, INC. | $44.17 | 2021-2024 | Brukinsa |
| G1 Therapeutics, INC. | $44.13 | 2022 | |
| Karyopharm Therapeutics INC. | $41.89 | 2020-2022 | |
| Tersera Therapeutics LLC | $41.54 | 2019 | |
| Stemline Therapeutics INC. | $37.13 | 2025 | Orserdu |
| Springworks Therapeutics, INC. | $35.31 | 2025 | Ogsiveo |
| Alexion Pharmaceuticals, INC. | $30.58 | 2023 | Ultomiris |
| Tempus Ai, INC | $28.17 | 2025 | Xt Cdx |
| Advanced Accelerator Applications | $26.78 | 2019 | |
| Abbvie INC. | $25.43 | 2024 | |
| Palette Life Sciences, INC. | $25.14 | 2023 | |
| Heron Therapeutics, INC. | $24.59 | 2019 | |
| Rigel Pharmaceuticals, INC. | $24.57 | 2019 | |
| Servier Pharmaceuticals LLC | $24.55 | 2025 | |
| Napo Pharmaceuticals INC | $21.18 | 2025 | Gelclair Concentrated Oral Gel |
| Genentech USA, INC. | $20.86 | 2024 | Itovebi, Polivy |
| Eisai INC. | $20.76 | 2020 | |
| Medtronic USA, INC. | $18.95 | 2020 | |
| Kite Pharma, INC. | $17.88 | 2024 | Yescarta |
| Clovis Oncology, INC. | $17.30 | 2021 | |
| Celgene Corporation | $16.88 | 2022 | |
| Apellis Pharmaceuticals, INC. | $15.15 | 2023 | |
| Tesaro, INC. | $14.88 | 2019 | |
| Taiho Oncology, INC. | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sukhjeet Batth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.